Irritable bowel syndrome. A poorly understood disorder.
Lewis
C
C
D002243:Carbolines / Q000009:adverse effects* / Q000627:therapeutic use; D003109:Colonic Diseases, Functional / Q000503:physiopathology* / Q000628:therapy; D004032:Diet; D004335:Drug and Narcotic Control; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D002243:Carbolines; D005765:Gastrointestinal Agents; C090840:alosetron